S. KADAYIFÇILAR And B. Eldem, "Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Associated with Central Serous Chorioretinopathy," OPHTHALMOLOGICA , vol.232, pp.59, 2014
KADAYIFÇILAR, S. And Eldem, B. 2014. Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Associated with Central Serous Chorioretinopathy. OPHTHALMOLOGICA , vol.232 , 59.
KADAYIFÇILAR, S., & Eldem, B., (2014). Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Associated with Central Serous Chorioretinopathy. OPHTHALMOLOGICA , vol.232, 59.
KADAYIFÇILAR, SİBEL, And Bora Eldem. "Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Associated with Central Serous Chorioretinopathy," OPHTHALMOLOGICA , vol.232, 59, 2014
KADAYIFÇILAR, SİBEL And Eldem, Bora. "Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Associated with Central Serous Chorioretinopathy." OPHTHALMOLOGICA , vol.232, pp.59, 2014
KADAYIFÇILAR, S. And Eldem, B. (2014) . "Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Associated with Central Serous Chorioretinopathy." OPHTHALMOLOGICA , vol.232, p.59.
@article{article, author={SİBEL KADAYIFÇILAR And author={Bora Eldem}, title={Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Associated with Central Serous Chorioretinopathy}, journal={OPHTHALMOLOGICA}, year=2014, pages={59} }